DePuy fracture program could help ease CMS pains

Newly proposed Centers for Medicare & Medicaid (CMS) programs could be made a bit easier to deal with thanks to Johnson & Johnson Medical Devices Companies. DePuy Synthes’ Geriatric Fracture Program could help hospitals work through the proposed mandatory coordinated care/episode payment programs.

The CMS proposal--which was filed in the Federal Register on August 2--would compensate care providers for an “episode” of care rather than individual care components. The episode would include the inpatient stay and 90 days after discharge. Treatments for surgical hip/femur fracture treatment, acute myocardial infarction and coronary artery bypass graft are included in the proposal.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

"The CMS proposal accelerates the drive toward a more integrated, value-based health care system in the US," said Tim Schmid, chief strategic customer officer at Johnson & Johnson Medical Devices Companies, in a statement. "By its very design, the Geriatric Fracture Program significantly elevates the ability of hospitals to meet the goals of the Triple Aim by improving patient outcomes, reducing costs and enhancing the patient experience.”

In addition to the Geriatric Fracture Program, Johnson & Johnson offers a suite of programs aimed at “operational integration and efficiency, continuum of care, and patient engagement and experience,” Johnson & Johnson explained in the announcement.

The Geriatric Fracture Program specifically has four components that would “complement” the proposed CMS program. This includes assessing whether a facility is ready to implement the program, support during implementation, materials assisting in implementation and a performance dashboard that would help to collect data and metrics.

According to Johnson & Johnson, the Geriatric Fracture Program has helped to address morbidity, mortality and cost. Studies have found “reductions in length of stay, post-operative delirium, and in-hospital post-operative falls,” the company explained in the announcement.

- here's the press release
- and here's the CMS's filing

Related Articles:
J&J's DePuy comes under fire for all-metal hip manufacturing in U.K.
J&J's DePuy buys shape-changing, minimally invasive small bone fixation tech startup
J&J Depuy does a pair of deals, one to treat disc degeneration and another for bundled payments

Suggested Articles

The FDA warned healthcare providers about cybersecurity vulnerabilities within certain clinical information systems made by GE Healthcare.

Weeks after receiving FDA approval for its in-office eardrum tube device, Tusker Medical has been picked up by Smith & Nephew for an undisclosed sum.

What a difference a day makes in biotech.